Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CV Sciences Inc CVSI

Healthcare Biotechnology
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under +PlusCBD, +PlusHLTH, Cultured Foods, and Lunar Fox brands in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its... see more

Recent & Breaking News (OTCQB:CVSI)

CV Sciences, Inc. Applauds Governor Abbot's Veto of Senate Bill 3

ACCESS Newswire June 23, 2025

CV Sciences, Inc. Reports First Quarter 2025 Financial Results

ACCESS Newswire May 14, 2025

CV Sciences, Inc. to Announce First Quarter 2025 Results on May 14, 2025

ACCESS Newswire May 9, 2025

CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results

ACCESS Newswire March 27, 2025

CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods

ACCESS Newswire March 26, 2025

CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025

ACCESS Newswire March 20, 2025

CV Sciences Unveils New Aura Collection THC Fizz Tablets

ACCESS Newswire February 5, 2025

CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs

PR Newswire November 21, 2024

CV Sciences, Inc. Reports Third Quarter 2024 Financial Results

PR Newswire November 14, 2024

CV Sciences, Inc. To Announce Third Quarter 2024 Results On November 14, 2024

PR Newswire November 8, 2024

CV Sciences Launches +PlusHLTH, a New Line of Cannabinoid-Free Supplements

PR Newswire August 27, 2024

CV Sciences, Inc. Reports Second Quarter 2024 Financial Results

PR Newswire August 13, 2024

CV Sciences, Inc. To Announce Second Quarter 2024 Results On August 13, 2024

PR Newswire August 7, 2024

CV Sciences, Inc. Reports First Quarter 2024 Financial Results

PR Newswire May 14, 2024

CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER

PR Newswire May 13, 2024

CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024

PR Newswire May 8, 2024

CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results

PR Newswire March 28, 2024

CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews

PR Newswire March 26, 2024

CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024

PR Newswire March 21, 2024

CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market, Opening Door For European Distribution

PR Newswire December 12, 2023